Evidence map›Paper›PMID 31354198›Full record

ArticleBioinformation2019

Analysis of salt-bridges in prolyl oligopeptidase from Pyrococcus furiosus and Homo sapiens.

Amal Kumar Bandyopadhyay, Rifat Nawaz Ul Islam, Debanjan Mitra, Sahini Banerjee, Arunava Goswami

Open access · hybridAbstract read
In one paragraph

Article in Bioinformation, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.2field-weighted citation impact, top 42% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Amal Kumar BandyopadhyayDepartment of Biotechnology, The University of Burdwan, Burdwan, West Bengal, India.
Rifat Nawaz Ul IslamDepartment of Zoology, The University of Burdwan, Burdwan, West Bengal, India.
Debanjan MitraDepartment of Biotechnology, The University of Burdwan, Burdwan, West Bengal, India.
Sahini BanerjeeDepartment of Biological Sciences, ISI, Kolkata, West Bengal, India.
Arunava GoswamiDepartment of Biological Sciences, ISI, Kolkata, West Bengal, India.
University of Burdwan · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hyper thermophilic archaea not only tolerate high temperature but also operate its biochemical machineries, normally under these conditions. However, the structural signatures in proteins that answer for the hyper thermo-stability relative to its mesophilic homologue remains poorly understood. We present comparative analyses of sequences, structures and salt-bridges of prolyl-oligopeptidase from Pyrococcus furiosus (pfPOP - PDB ID: 5T88) and human (huPOP - PDB ID: 3DDU). A similar level of hydrophobic and hydrophilic residues in pfPOP and huPOP is observed. A low level of interactions between shell-waters and atom-types in pfPOP indicated hyper thermophilic features are negligible. Salt-bridge-forming-residues (sbfrs) are high in pfPOP's core and surface (pfPOP). Increased sbfrs largely indicate specific-electrostatic is important for thermo stability in pfPOP. Four classes of sbfrs are found namely positionally non-conservative (PNCS), conservative (PCS), unchanged (PU) and interchanged (PIC) type of substitutions. PNCS-sbfrs constitutes 28% and it is associated with the topology of pfPOP at high temperature. PCS helps to increase the salt-bridge population. It is also found that PU maintains similar salt-bridges at the active site and other binding sites while PIC abolishes mesophilic patterns.

Indexed as

electrostaticsprolyl oligo peptidasesalt bridgesalt bridge designThermo stability

Identifiers

PMID31354198
PMCPMC6637400
OpenAlexW2955038103

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.